Key Events This Week
2 Mar: Stock opens week at Rs.2,311.60, outperforming Sensex decline
5 Mar: Lupin hits new 52-week high of Rs.2,360.5, signalling strong momentum
6 Mar: Fresh 52-week high of Rs.2,368 reached alongside significant open interest surge
6 Mar: Week closes at Rs.2,344.45, up 1.87% vs Sensex down 3.00%
2 March 2026: Positive Start Amid Market Weakness
Lupin Ltd commenced the week on a positive note, closing at Rs.2,311.60, up 0.45% from the previous Friday’s close of Rs.2,301.35. This gain was notable given the Sensex’s sharp decline of 1.41% to 35,812.02 on the same day, reflecting Lupin’s relative strength in a broadly weak market. The stock’s volume of 17,859 shares indicated steady investor interest despite the negative market sentiment.
5 March 2026: New 52-Week High and Strong Financial Backing
On 5 March, Lupin Ltd surged to a new 52-week high of Rs.2,360.5 intraday, closing at Rs.2,332.40, a robust 1.21% increase. This milestone underscored the stock’s strong momentum, supported by solid financial fundamentals. The company’s net sales have grown at an annualised rate of 11.42%, with operating profit margins at a healthy 33.60%. Quarterly profit before tax rose 43.6% to Rs.1,833.91 crores, reinforcing confidence in Lupin’s operational strength.
Technically, Lupin traded above all key moving averages, signalling sustained upward momentum. The stock outperformed its sector peers by 0.54% on the day, closing amid a positive market backdrop where the Sensex gained 1.29%. Institutional holdings remain strong at 47.08%, reflecting continued confidence from major investors.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
6 March 2026: Fresh 52-Week High and Surge in Derivatives Activity
Lupin Ltd extended its gains on 6 March, hitting a new 52-week high of Rs.2,368 intraday and closing at Rs.2,344.45, up 0.52%. This marked a cumulative return of 1.83% over the last two trading sessions. The stock continued to trade above all major moving averages, signalling strong technical momentum despite the Sensex’s 0.98% decline to 35,232.05.
Notably, Lupin witnessed a significant 12.3% surge in open interest in its derivatives segment, rising from 26,813 to 30,117 contracts. This increase was accompanied by a high volume of 26,510 contracts and a total derivatives value exceeding ₹29,418.42 lakhs, indicating fresh bullish positioning by market participants. Delivery volumes also spiked by 86.81% compared to the five-day average, suggesting genuine accumulation rather than speculative trading.
The stock outperformed its sector with a 0.50% gain against the Pharmaceuticals & Biotechnology sector’s 0.21% rise, highlighting Lupin’s resilience amid mixed market conditions. The company’s strong fundamentals, including a low debt-to-equity ratio of 0.10 times and impressive return metrics (ROCE 22.22%, ROE 22%), underpin this positive momentum.
Curious about Lupin Ltd. from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-02 | Rs.2,311.60 | +0.45% | 35,812.02 | -1.41% |
| 2026-03-04 | Rs.2,304.45 | -0.31% | 35,125.64 | -1.92% |
| 2026-03-05 | Rs.2,332.40 | +1.21% | 35,579.03 | +1.29% |
| 2026-03-06 | Rs.2,344.45 | +0.52% | 35,232.05 | -0.98% |
Key Takeaways
Outperformance Amid Market Volatility: Lupin Ltd’s 1.87% weekly gain contrasted sharply with the Sensex’s 3.00% decline, highlighting the stock’s defensive qualities and investor preference amid broader market weakness.
Strong Financial and Operational Metrics: The company’s robust net sales growth of 11.42% annually, operating profit margin of 33.60%, and a 43.6% jump in quarterly profit before tax underpin the stock’s upward trajectory. Return ratios such as ROCE (22.22%) and ROE (22%) further demonstrate efficient capital utilisation.
Technical Momentum and Market Participation: Lupin’s consistent trading above all key moving averages and fresh 52-week highs signal sustained technical strength. The significant surge in derivatives open interest and delivery volumes indicates active accumulation and bullish positioning by institutional and retail investors alike.
Valuation and Ratings: Despite recent gains, Lupin’s valuation remains attractive with a price-to-book ratio of 5.4 and a PEG ratio of 0.3, suggesting earnings growth outpaces price appreciation. The Mojo Score of 78.0 and a Buy rating reflect a positive but slightly moderated outlook following a downgrade from Strong Buy.
Conclusion
Lupin Ltd’s performance during the week of 2 to 6 March 2026 was marked by resilience and strength, as it navigated a challenging market environment to deliver gains while the broader Sensex declined. The stock’s fresh 52-week highs, underpinned by solid financial results and increasing derivatives market activity, reflect sustained investor confidence and technical momentum. While the recent downgrade from Strong Buy to Buy suggests a more cautious stance, Lupin’s fundamentals and market positioning continue to support its status as a noteworthy contender within the Pharmaceuticals & Biotechnology sector. Investors should monitor ongoing market dynamics and derivatives activity for further directional cues.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
